Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Yu Fujita, Roberto Tinoco, Yan Li, Daniela Senft, Ze'ev A Ronai

Trends in molecular medicine 2019 May

filter terms:

Considerable progress has been made in understanding the contribution of E3 ubiquitin ligases to health and disease, including the pathogenesis of immunological disorders. Ubiquitin ligases exert exquisite spatial and temporal control over protein stability and function, and are thus crucial for the regulation of both innate and adaptive immunity. Given that immune responses can be both detrimental (autoimmunity) and beneficial (antitumor immunity), it is vital to understand how ubiquitin ligases maintain immunological homeostasis. Such knowledge could reveal novel mechanisms underlying immune regulation and identify new therapeutic approaches to enhance antitumor immunity and safeguard against autoimmunity. Copyright © 2019 Elsevier Ltd. All rights reserved.

Citation

Yu Fujita, Roberto Tinoco, Yan Li, Daniela Senft, Ze'ev A Ronai. Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity. Trends in molecular medicine. 2019 May;25(5):428-443